Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.90252984 |
2 | modulation by symbiont of host defense response (GO:0052031) | 6.90252984 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.90252984 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.90252984 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.90252984 |
6 | modulation by symbiont of host immune response (GO:0052553) | 6.90252984 |
7 | response to peptidoglycan (GO:0032494) | 6.36479459 |
8 | neutrophil activation involved in immune response (GO:0002283) | 5.30804474 |
9 | macrophage activation involved in immune response (GO:0002281) | 5.19633669 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.06681887 |
11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.76982821 |
12 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.70681787 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.65310665 |
14 | negative regulation of cell killing (GO:0031342) | 4.65310665 |
15 | microglial cell activation (GO:0001774) | 4.61207897 |
16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.61164529 |
17 | response to host immune response (GO:0052572) | 4.61164529 |
18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.59196766 |
19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.52231083 |
20 | positive regulation of interferon-alpha production (GO:0032727) | 4.45302406 |
21 | immunoglobulin mediated immune response (GO:0016064) | 4.34822522 |
22 | respiratory burst (GO:0045730) | 4.32340245 |
23 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.29041426 |
24 | detection of other organism (GO:0098543) | 4.28838410 |
25 | regulation of interferon-alpha production (GO:0032647) | 4.27362741 |
26 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.19149065 |
27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.18942674 |
28 | response to host (GO:0075136) | 4.18632564 |
29 | response to host defenses (GO:0052200) | 4.18632564 |
30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.18632564 |
31 | detection of bacterium (GO:0016045) | 4.05563231 |
32 | positive regulation of heat generation (GO:0031652) | 4.02895228 |
33 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.95043305 |
34 | detection of molecule of bacterial origin (GO:0032490) | 3.94397564 |
35 | macrophage activation (GO:0042116) | 3.90597522 |
36 | regulation of chemokine biosynthetic process (GO:0045073) | 3.90208567 |
37 | regulation of mononuclear cell migration (GO:0071675) | 3.83938660 |
38 | regulation of fever generation (GO:0031620) | 3.83863761 |
39 | granulocyte activation (GO:0036230) | 3.82959808 |
40 | myeloid cell activation involved in immune response (GO:0002275) | 3.77029431 |
41 | superoxide anion generation (GO:0042554) | 3.76891276 |
42 | negative regulation of interleukin-17 production (GO:0032700) | 3.76221691 |
43 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.70249349 |
44 | response to muramyl dipeptide (GO:0032495) | 3.70182165 |
45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.70113473 |
46 | lymphocyte chemotaxis (GO:0048247) | 3.68919540 |
47 | reactive oxygen species biosynthetic process (GO:1903409) | 3.68909263 |
48 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.68640925 |
49 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.66701262 |
50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.65503054 |
51 | amino sugar catabolic process (GO:0046348) | 3.63102380 |
52 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.63066753 |
53 | positive regulation of mast cell degranulation (GO:0043306) | 3.63066753 |
54 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.61845231 |
55 | glycosphingolipid catabolic process (GO:0046479) | 3.57643749 |
56 | regulation of leukocyte degranulation (GO:0043300) | 3.55836487 |
57 | negative regulation of interleukin-12 production (GO:0032695) | 3.53502292 |
58 | neutrophil activation (GO:0042119) | 3.51676075 |
59 | detection of biotic stimulus (GO:0009595) | 3.51620130 |
60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.50990073 |
61 | positive regulation of mast cell activation (GO:0033005) | 3.49478242 |
62 | cellular extravasation (GO:0045123) | 3.48489549 |
63 | regulation of macrophage chemotaxis (GO:0010758) | 3.46733118 |
64 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43291974 |
65 | positive regulation of interferon-beta production (GO:0032728) | 3.41815155 |
66 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39059024 |
67 | N-acetylneuraminate metabolic process (GO:0006054) | 3.36302872 |
68 | positive regulation of macrophage cytokine production (GO:0060907) | 3.34543933 |
69 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.33836800 |
70 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29309066 |
71 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.28678026 |
72 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28000360 |
73 | positive regulation of chemokine production (GO:0032722) | 3.26553030 |
74 | regulation of mast cell degranulation (GO:0043304) | 3.26423821 |
75 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.24560460 |
76 | eosinophil chemotaxis (GO:0048245) | 3.23035484 |
77 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.21775024 |
78 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.20400893 |
79 | glycolipid catabolic process (GO:0019377) | 3.19649270 |
80 | cellular response to zinc ion (GO:0071294) | 3.19012562 |
81 | I-kappaB phosphorylation (GO:0007252) | 3.18877644 |
82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18068804 |
83 | T-helper 1 type immune response (GO:0042088) | 3.17715628 |
84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17701965 |
85 | leukocyte aggregation (GO:0070486) | 3.17630180 |
86 | positive regulation of leukocyte degranulation (GO:0043302) | 3.16742906 |
87 | regulation of interleukin-17 production (GO:0032660) | 3.15634583 |
88 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.13792944 |
89 | B cell mediated immunity (GO:0019724) | 3.12168247 |
90 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.11664043 |
91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.11191605 |
92 | monocyte chemotaxis (GO:0002548) | 3.09732405 |
93 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.09485178 |
94 | oligosaccharide catabolic process (GO:0009313) | 3.09119241 |
95 | type I interferon signaling pathway (GO:0060337) | 3.08622983 |
96 | cellular response to type I interferon (GO:0071357) | 3.08622983 |
97 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.06194368 |
98 | regulation of heat generation (GO:0031650) | 3.05189455 |
99 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.04845170 |
100 | regulation of mast cell activation (GO:0033003) | 3.04160749 |
101 | positive regulation of interleukin-10 production (GO:0032733) | 3.03619366 |
102 | response to type I interferon (GO:0034340) | 3.03473055 |
103 | positive regulation of lymphocyte migration (GO:2000403) | 3.03300208 |
104 | regulation of antigen processing and presentation (GO:0002577) | 3.03118438 |
105 | positive regulation of interleukin-12 production (GO:0032735) | 3.03016809 |
106 | neutrophil chemotaxis (GO:0030593) | 3.02760258 |
107 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00019423 |
108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99557740 |
109 | positive regulation of interleukin-6 production (GO:0032755) | 2.99120044 |
110 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.98740487 |
111 | neutrophil migration (GO:1990266) | 2.94317387 |
112 | macrophage differentiation (GO:0030225) | 2.94226105 |
113 | cellular response to interferon-beta (GO:0035458) | 2.93719306 |
114 | response to thyroid hormone (GO:0097066) | 2.93284310 |
115 | regulation of T cell tolerance induction (GO:0002664) | 2.93169267 |
116 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.93136457 |
117 | barbed-end actin filament capping (GO:0051016) | 2.92991565 |
118 | detection of external biotic stimulus (GO:0098581) | 2.92213983 |
119 | neutrophil mediated immunity (GO:0002446) | 2.92131993 |
120 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92054140 |
121 | * positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.92052330 |
122 | defense response to protozoan (GO:0042832) | 2.92030120 |
123 | NIK/NF-kappaB signaling (GO:0038061) | 2.91840446 |
124 | response to interferon-beta (GO:0035456) | 2.91298250 |
125 | myeloid dendritic cell differentiation (GO:0043011) | 2.90785170 |
126 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89921444 |
127 | leukocyte mediated cytotoxicity (GO:0001909) | 2.88825566 |
128 | regulation of regulated secretory pathway (GO:1903305) | 2.88584730 |
129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.88288158 |
130 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.88073131 |
131 | eosinophil migration (GO:0072677) | 2.87444493 |
132 | germinal center formation (GO:0002467) | 2.86893593 |
133 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.86859341 |
134 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.86475509 |
135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86095982 |
136 | ceramide catabolic process (GO:0046514) | 2.85182195 |
137 | myeloid leukocyte activation (GO:0002274) | 2.84419516 |
138 | phagosome maturation (GO:0090382) | 2.83427176 |
139 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81959204 |
140 | myeloid dendritic cell activation (GO:0001773) | 2.78466689 |
141 | regulation of tolerance induction (GO:0002643) | 2.77237318 |
142 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.72070560 |
143 | response to protozoan (GO:0001562) | 2.71415365 |
144 | regulation of superoxide anion generation (GO:0032928) | 2.70652652 |
145 | regulation of podosome assembly (GO:0071801) | 2.65985345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.86100105 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.19083767 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.24907402 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.66504907 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.41567463 |
6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.90295283 |
7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.86924156 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72328274 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42880176 |
10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.39691506 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15818812 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.12724150 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.99942995 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86379119 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65881928 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59686557 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57996343 |
18 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44406775 |
19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32622842 |
20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24201427 |
21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16122165 |
22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11271819 |
23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.05199039 |
24 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99439384 |
25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.96833523 |
26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84817170 |
27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.81103886 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78315589 |
29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75561498 |
30 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.74501912 |
31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73853449 |
32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72203088 |
33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66103720 |
34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.60724347 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60537343 |
36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57062682 |
37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55841059 |
38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55414996 |
39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54853073 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52694743 |
41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.48589013 |
42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45589749 |
43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44928795 |
44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44017675 |
45 | MYC_22102868_ChIP-Seq_BL_Human | 1.41290722 |
46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38640485 |
47 | MYB_26560356_Chip-Seq_TH2_Human | 1.38261363 |
48 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35064937 |
49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34774978 |
50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34585357 |
51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33921693 |
52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32553290 |
53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29918988 |
54 | MAF_26560356_Chip-Seq_TH2_Human | 1.28261579 |
55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25071119 |
56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23231530 |
57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22979238 |
58 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22271528 |
59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22218179 |
60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21738700 |
61 | MAF_26560356_Chip-Seq_TH1_Human | 1.21284338 |
62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18670743 |
63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17941653 |
64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17911264 |
65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17241234 |
66 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13501063 |
67 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.13373347 |
68 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11521563 |
69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10333836 |
70 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09184827 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07016004 |
72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06117767 |
73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.05275210 |
74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04489855 |
75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03970411 |
76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02792110 |
77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02408544 |
78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02408544 |
79 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01673832 |
80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01379127 |
81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01263302 |
82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01112195 |
83 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.99966439 |
84 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99941632 |
85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98427453 |
86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97765846 |
87 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97324020 |
88 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97225230 |
89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96724218 |
90 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95954566 |
91 | MYB_26560356_Chip-Seq_TH1_Human | 0.95604520 |
92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95017993 |
93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94559208 |
94 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94289034 |
95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94084868 |
96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93583161 |
97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93017730 |
98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90915712 |
99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90867625 |
100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90078757 |
101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89960639 |
102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89372669 |
103 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88099763 |
104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87628551 |
105 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86185759 |
106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85575749 |
107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85008429 |
108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85008214 |
109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85008214 |
110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84014649 |
111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81829985 |
112 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80579667 |
113 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79871382 |
114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77740914 |
115 | UTX_26944678_Chip-Seq_JUKART_Human | 0.77357639 |
116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76135493 |
117 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75971120 |
118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73743501 |
119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71641224 |
120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70643131 |
121 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.70573031 |
122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69836598 |
123 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.69508053 |
124 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68524547 |
125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.67362410 |
126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.64045429 |
127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.61506506 |
128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.60294781 |
129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.60083539 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 4.23915554 |
2 | MP0001835_abnormal_antigen_presentation | 4.13198741 |
3 | * MP0009785_altered_susceptibility_to | 3.91933122 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.88507836 |
5 | MP0006082_CNS_inflammation | 3.72530571 |
6 | MP0003303_peritoneal_inflammation | 3.71975440 |
7 | MP0003724_increased_susceptibility_to | 3.44101698 |
8 | * MP0002419_abnormal_innate_immunity | 3.41088281 |
9 | MP0005058_abnormal_lysosome_morphology | 3.30082291 |
10 | MP0005000_abnormal_immune_tolerance | 3.29696820 |
11 | * MP0005025_abnormal_response_to | 2.96157769 |
12 | * MP0002452_abnormal_antigen_presenting | 2.52246216 |
13 | MP0001790_abnormal_immune_system | 2.50017507 |
14 | MP0005387_immune_system_phenotype | 2.50017507 |
15 | MP0004510_myositis | 2.45593974 |
16 | MP0001533_abnormal_skeleton_physiology | 2.40163828 |
17 | * MP0002723_abnormal_immune_serum | 2.36664864 |
18 | MP0001800_abnormal_humoral_immune | 2.33283480 |
19 | MP0009764_decreased_sensitivity_to | 2.24401906 |
20 | MP0003075_altered_response_to | 2.20003363 |
21 | MP0000343_altered_response_to | 2.17580015 |
22 | MP0005167_abnormal_blood-brain_barrier | 2.14729935 |
23 | MP0005671_abnormal_response_to | 2.13256688 |
24 | MP0000685_abnormal_immune_system | 2.12157399 |
25 | MP0005464_abnormal_platelet_physiology | 2.11757567 |
26 | * MP0001819_abnormal_immune_cell | 2.05596470 |
27 | * MP0002420_abnormal_adaptive_immunity | 2.02723590 |
28 | MP0004947_skin_inflammation | 2.01080691 |
29 | MP0002139_abnormal_hepatobiliary_system | 2.00614285 |
30 | MP0003448_altered_tumor_morphology | 1.97092993 |
31 | MP0003172_abnormal_lysosome_physiology | 1.95415962 |
32 | * MP0001845_abnormal_inflammatory_respons | 1.92114740 |
33 | MP0001853_heart_inflammation | 1.88928776 |
34 | MP0002405_respiratory_system_inflammati | 1.87740397 |
35 | MP0003806_abnormal_nucleotide_metabolis | 1.81719331 |
36 | MP0009278_abnormal_bone_marrow | 1.78812541 |
37 | * MP0008469_abnormal_protein_level | 1.76129921 |
38 | MP0003191_abnormal_cellular_cholesterol | 1.74057038 |
39 | MP0005166_decreased_susceptibility_to | 1.73571545 |
40 | MP0000604_amyloidosis | 1.73396528 |
41 | MP0010155_abnormal_intestine_physiology | 1.69194114 |
42 | MP0003690_abnormal_glial_cell | 1.66740474 |
43 | MP0002006_tumorigenesis | 1.61309265 |
44 | MP0002998_abnormal_bone_remodeling | 1.59226795 |
45 | MP0000858_altered_metastatic_potential | 1.53752392 |
46 | MP0009333_abnormal_splenocyte_physiolog | 1.50884804 |
47 | MP0005310_abnormal_salivary_gland | 1.47892780 |
48 | MP0009840_abnormal_foam_cell | 1.45519589 |
49 | MP0005164_abnormal_response_to | 1.42253515 |
50 | MP0003300_gastrointestinal_ulcer | 1.41152087 |
51 | MP0005451_abnormal_body_composition | 1.36513748 |
52 | MP0000716_abnormal_immune_system | 1.34750164 |
53 | MP0002277_abnormal_respiratory_mucosa | 1.28636135 |
54 | MP0003195_calcinosis | 1.24223938 |
55 | MP0002254_reproductive_system_inflammat | 1.23365647 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.20214532 |
57 | MP0001545_abnormal_hematopoietic_system | 1.20214532 |
58 | MP0003329_amyloid_beta_deposits | 1.18452081 |
59 | MP0005390_skeleton_phenotype | 1.15922814 |
60 | MP0002398_abnormal_bone_marrow | 1.15859279 |
61 | MP0005365_abnormal_bile_salt | 1.14461705 |
62 | MP0005076_abnormal_cell_differentiation | 1.10548585 |
63 | MP0009763_increased_sensitivity_to | 1.06481388 |
64 | MP0003186_abnormal_redox_activity | 1.05611835 |
65 | MP0002429_abnormal_blood_cell | 1.05412004 |
66 | MP0000689_abnormal_spleen_morphology | 1.04248816 |
67 | MP0004782_abnormal_surfactant_physiolog | 1.04196292 |
68 | MP0002933_joint_inflammation | 1.00951222 |
69 | MP0003453_abnormal_keratinocyte_physiol | 1.00810967 |
70 | MP0004883_abnormal_blood_vessel | 0.95742559 |
71 | MP0000249_abnormal_blood_vessel | 0.94907934 |
72 | MP0002332_abnormal_exercise_endurance | 0.94763371 |
73 | MP0001851_eye_inflammation | 0.94676586 |
74 | MP0002722_abnormal_immune_system | 0.89101696 |
75 | MP0006054_spinal_hemorrhage | 0.88245612 |
76 | MP0003566_abnormal_cell_adhesion | 0.87340985 |
77 | MP0004858_abnormal_nervous_system | 0.80004086 |
78 | MP0010352_gastrointestinal_tract_polyps | 0.79681194 |
79 | MP0010307_abnormal_tumor_latency | 0.79625643 |
80 | MP0003183_abnormal_peptide_metabolism | 0.77471582 |
81 | MP0002837_dystrophic_cardiac_calcinosis | 0.77104301 |
82 | MP0003763_abnormal_thymus_physiology | 0.75066002 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 0.74211155 |
84 | MP0008260_abnormal_autophagy | 0.74004310 |
85 | MP0002132_abnormal_respiratory_system | 0.73690713 |
86 | MP0008874_decreased_physiological_sensi | 0.72993737 |
87 | MP0001542_abnormal_bone_strength | 0.71297727 |
88 | MP0005257_abnormal_intraocular_pressure | 0.71292389 |
89 | MP0000465_gastrointestinal_hemorrhage | 0.70543718 |
90 | MP0005023_abnormal_wound_healing | 0.70018723 |
91 | MP0009765_abnormal_xenobiotic_induced | 0.69314607 |
92 | MP0002166_altered_tumor_susceptibility | 0.68557282 |
93 | MP0008004_abnormal_stomach_pH | 0.68475782 |
94 | MP0002138_abnormal_hepatobiliary_system | 0.67484592 |
95 | MP0000920_abnormal_myelination | 0.67379688 |
96 | MP0003279_aneurysm | 0.67124288 |
97 | MP0003866_abnormal_defecation | 0.66836036 |
98 | * MP0003795_abnormal_bone_structure | 0.66443231 |
99 | MP0008873_increased_physiological_sensi | 0.66169799 |
100 | MP0002136_abnormal_kidney_physiology | 0.65916934 |
101 | MP0003091_abnormal_cell_migration | 0.65916845 |
102 | MP0005165_increased_susceptibility_to | 0.60677273 |
103 | * MP0003828_pulmonary_edema | 0.60016645 |
104 | MP0002295_abnormal_pulmonary_circulatio | 0.59767697 |
105 | MP0003045_fibrosis | 0.59536612 |
106 | MP0005083_abnormal_biliary_tract | 0.58802432 |
107 | MP0000569_abnormal_digit_pigmentation | 0.58793339 |
108 | MP0001849_ear_inflammation | 0.57337044 |
109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57038903 |
110 | MP0001881_abnormal_mammary_gland | 0.57019671 |
111 | MP0003634_abnormal_glial_cell | 0.56887200 |
112 | MP0000371_diluted_coat_color | 0.55723621 |
113 | MP0001873_stomach_inflammation | 0.53612354 |
114 | MP0001663_abnormal_digestive_system | 0.53200838 |
115 | MP0000767_abnormal_smooth_muscle | 0.52879753 |
116 | MP0000490_abnormal_crypts_of | 0.52671711 |
117 | MP0005319_abnormal_enzyme/_coenzyme | 0.51057490 |
118 | MP0000609_abnormal_liver_physiology | 0.50810366 |
119 | MP0005595_abnormal_vascular_smooth | 0.49329597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.97618136 |
2 | Eczematoid dermatitis (HP:0000976) | 7.20877668 |
3 | Recurrent bacterial skin infections (HP:0005406) | 7.17220887 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.33709080 |
5 | Systemic lupus erythematosus (HP:0002725) | 6.01978966 |
6 | Abnormality of macrophages (HP:0004311) | 5.31395641 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 5.25162783 |
8 | Stomatitis (HP:0010280) | 5.20840663 |
9 | Increased cerebral lipofuscin (HP:0011813) | 5.01083188 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.90664485 |
11 | Vacuolated lymphocytes (HP:0001922) | 4.85203817 |
12 | Orchitis (HP:0100796) | 4.42333017 |
13 | Gingivitis (HP:0000230) | 4.39814891 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.26114479 |
15 | Myositis (HP:0100614) | 4.22832409 |
16 | Glomerulonephritis (HP:0000099) | 4.17476331 |
17 | Optic neuritis (HP:0100653) | 4.16662864 |
18 | Retrobulbar optic neuritis (HP:0100654) | 4.16662864 |
19 | Recurrent skin infections (HP:0001581) | 4.04002508 |
20 | Axonal loss (HP:0003447) | 4.00859058 |
21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.90299369 |
22 | Obstructive lung disease (HP:0006536) | 3.90299369 |
23 | Autoimmune thrombocytopenia (HP:0001973) | 3.77276654 |
24 | Thick nail (HP:0001805) | 3.73514685 |
25 | Mutism (HP:0002300) | 3.70992170 |
26 | Pustule (HP:0200039) | 3.68465936 |
27 | Disinhibition (HP:0000734) | 3.54710415 |
28 | Prostate neoplasm (HP:0100787) | 3.51506858 |
29 | Dysostosis multiplex (HP:0000943) | 3.42636761 |
30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.37799803 |
31 | Interstitial pulmonary disease (HP:0006530) | 3.32893265 |
32 | Recurrent fungal infections (HP:0002841) | 3.27945100 |
33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.18934291 |
34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15702164 |
35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15702164 |
36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15702164 |
37 | Basal ganglia calcification (HP:0002135) | 3.14073051 |
38 | Vasculitis (HP:0002633) | 3.13025696 |
39 | Cellulitis (HP:0100658) | 3.02609844 |
40 | Neurofibrillary tangles (HP:0002185) | 2.99792131 |
41 | Urticaria (HP:0001025) | 2.98741862 |
42 | Increased serum ferritin (HP:0003281) | 2.92301577 |
43 | Agnosia (HP:0010524) | 2.88328454 |
44 | Periodontitis (HP:0000704) | 2.87425015 |
45 | Pulmonary infiltrates (HP:0002113) | 2.86348753 |
46 | Nephritis (HP:0000123) | 2.84333014 |
47 | Abnormality of complement system (HP:0005339) | 2.76264384 |
48 | Recurrent viral infections (HP:0004429) | 2.70851689 |
49 | Myocardial infarction (HP:0001658) | 2.61590035 |
50 | Increased IgM level (HP:0003496) | 2.58743847 |
51 | Hematochezia (HP:0002573) | 2.58121806 |
52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58002697 |
53 | Mucopolysacchariduria (HP:0008155) | 2.58002697 |
54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57621670 |
55 | Osteolytic defects of the hand bones (HP:0009699) | 2.57621670 |
56 | Tetraparesis (HP:0002273) | 2.56324302 |
57 | Neuronal loss in central nervous system (HP:0002529) | 2.54959308 |
58 | Recurrent pneumonia (HP:0006532) | 2.54238932 |
59 | Complement deficiency (HP:0004431) | 2.50003293 |
60 | Osteomyelitis (HP:0002754) | 2.47445360 |
61 | Abnormality of iron homeostasis (HP:0011031) | 2.44179393 |
62 | Keratoconjunctivitis sicca (HP:0001097) | 2.43477721 |
63 | Progressive visual loss (HP:0000529) | 2.42610566 |
64 | Meningitis (HP:0001287) | 2.39069999 |
65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38968465 |
66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38968465 |
67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38968465 |
68 | Petechiae (HP:0000967) | 2.38439881 |
69 | Nuclear cataract (HP:0100018) | 2.38212212 |
70 | Leukocytosis (HP:0001974) | 2.37344586 |
71 | Hepatosplenomegaly (HP:0001433) | 2.36420507 |
72 | Progressive neurologic deterioration (HP:0002344) | 2.32834099 |
73 | Malnutrition (HP:0004395) | 2.32507376 |
74 | Upper motor neuron abnormality (HP:0002127) | 2.29696803 |
75 | Arterial thrombosis (HP:0004420) | 2.27048004 |
76 | Premature loss of primary teeth (HP:0006323) | 2.22338414 |
77 | Keratoconjunctivitis (HP:0001096) | 2.19776804 |
78 | Encephalitis (HP:0002383) | 2.19361873 |
79 | Pulmonary embolism (HP:0002204) | 2.18920455 |
80 | Inappropriate behavior (HP:0000719) | 2.18576821 |
81 | Apathy (HP:0000741) | 2.16309183 |
82 | Bone pain (HP:0002653) | 2.15890485 |
83 | Increased IgE level (HP:0003212) | 2.15807623 |
84 | Retinal atrophy (HP:0001105) | 2.13453718 |
85 | Pathologic fracture (HP:0002756) | 2.12828705 |
86 | Cerebral inclusion bodies (HP:0100314) | 2.12247396 |
87 | Epistaxis (HP:0000421) | 2.11862660 |
88 | Joint hemorrhage (HP:0005261) | 2.11260649 |
89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10900383 |
90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10900383 |
91 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08278402 |
92 | Poor head control (HP:0002421) | 2.07737034 |
93 | Esophageal neoplasm (HP:0100751) | 2.06386247 |
94 | Neoplasm of head and neck (HP:0012288) | 2.06386247 |
95 | Spontaneous hematomas (HP:0007420) | 2.04032954 |
96 | Personality changes (HP:0000751) | 2.02866082 |
97 | Anorexia (HP:0002039) | 2.02698774 |
98 | Polyneuropathy (HP:0001271) | 2.00491199 |
99 | Abnormality of the pericardium (HP:0001697) | 2.00125324 |
100 | Hemoptysis (HP:0002105) | 2.00002526 |
101 | Nausea (HP:0002018) | 1.98565067 |
102 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96594468 |
103 | Episodic fever (HP:0001954) | 1.96045794 |
104 | Dementia (HP:0000726) | 1.95953442 |
105 | Abnormality of the prostate (HP:0008775) | 1.95584056 |
106 | Hypergammaglobulinemia (HP:0010702) | 1.94570286 |
107 | Loss of speech (HP:0002371) | 1.93457598 |
108 | Prolonged bleeding time (HP:0003010) | 1.92840284 |
109 | Metaphyseal irregularity (HP:0003025) | 1.92574826 |
110 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92480765 |
111 | Asymmetric septal hypertrophy (HP:0001670) | 1.91889228 |
112 | Amyloidosis (HP:0011034) | 1.89686359 |
113 | Abnormality of the pleura (HP:0002103) | 1.89598519 |
114 | Memory impairment (HP:0002354) | 1.89196738 |
115 | Conjunctival telangiectasia (HP:0000524) | 1.88664147 |
116 | Gastrointestinal infarctions (HP:0005244) | 1.88559364 |
117 | T lymphocytopenia (HP:0005403) | 1.88531592 |
118 | Purpura (HP:0000979) | 1.88053912 |
119 | Peritonitis (HP:0002586) | 1.85765622 |
120 | Arthralgia (HP:0002829) | 1.85064352 |
121 | Increased CSF protein (HP:0002922) | 1.85055358 |
122 | Gingival bleeding (HP:0000225) | 1.84372658 |
123 | Sepsis (HP:0100806) | 1.84223018 |
124 | Peripheral demyelination (HP:0011096) | 1.83885028 |
125 | Inflammation of the large intestine (HP:0002037) | 1.83070316 |
126 | Vertebral compression fractures (HP:0002953) | 1.82405841 |
127 | J-shaped sella turcica (HP:0002680) | 1.81080018 |
128 | Skin ulcer (HP:0200042) | 1.80265494 |
129 | Diminished motivation (HP:0000745) | 1.79295288 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.60868208 |
2 | BLK | 4.50105092 |
3 | RIPK4 | 4.40411295 |
4 | TBK1 | 3.76285193 |
5 | IRAK3 | 3.72109766 |
6 | IRAK4 | 3.11519031 |
7 | TYK2 | 2.91141413 |
8 | PBK | 2.75651960 |
9 | IKBKE | 2.68822023 |
10 | IKBKB | 2.48172849 |
11 | TXK | 2.37777471 |
12 | ERN1 | 2.19128631 |
13 | PRPF4B | 2.15012322 |
14 | MAP4K1 | 2.13596898 |
15 | TAOK1 | 1.94866998 |
16 | TGFBR2 | 1.91163875 |
17 | KIT | 1.89840028 |
18 | JAK3 | 1.88845746 |
19 | FGR | 1.82124686 |
20 | CSK | 1.76419736 |
21 | PIM2 | 1.74494695 |
22 | JAK1 | 1.74086515 |
23 | TNK2 | 1.71104197 |
24 | GRK7 | 1.69472379 |
25 | TAOK2 | 1.62609574 |
26 | CHUK | 1.57228004 |
27 | EPHB1 | 1.55460962 |
28 | NEK9 | 1.49646504 |
29 | CSF1R | 1.40694673 |
30 | ZAP70 | 1.39193786 |
31 | HCK | 1.31926509 |
32 | CAMKK2 | 1.30198413 |
33 | LYN | 1.29074912 |
34 | MAP3K13 | 1.28185295 |
35 | MATK | 1.25805197 |
36 | DDR2 | 1.25509980 |
37 | NME2 | 1.20928848 |
38 | STK10 | 1.19225769 |
39 | SYK | 1.18431711 |
40 | BMX | 1.15791692 |
41 | CDC42BPA | 1.12631944 |
42 | ABL2 | 1.11252243 |
43 | JAK2 | 1.10550433 |
44 | BTK | 1.09772412 |
45 | BMPR2 | 1.09706404 |
46 | SIK3 | 1.04239613 |
47 | TESK2 | 1.03541836 |
48 | EIF2AK2 | 1.02257058 |
49 | RPS6KA4 | 1.00507849 |
50 | LCK | 1.00282238 |
51 | ACVR1B | 0.97645190 |
52 | MST4 | 0.92671499 |
53 | MAP3K11 | 0.91781199 |
54 | PIM1 | 0.91339132 |
55 | FES | 0.91031532 |
56 | PRKCD | 0.90670914 |
57 | GRK6 | 0.90295068 |
58 | MARK3 | 0.90139564 |
59 | YES1 | 0.84703769 |
60 | MAP3K3 | 0.82423134 |
61 | MST1R | 0.82319769 |
62 | EGFR | 0.81560406 |
63 | MOS | 0.80976605 |
64 | TAOK3 | 0.74852789 |
65 | TRIB3 | 0.74297424 |
66 | KSR2 | 0.73169813 |
67 | TEC | 0.72099045 |
68 | EPHA3 | 0.72062439 |
69 | MARK2 | 0.71096823 |
70 | MAP3K5 | 0.70811305 |
71 | IRAK1 | 0.70211675 |
72 | ABL1 | 0.69724014 |
73 | ADRBK2 | 0.67340172 |
74 | PRKD2 | 0.64521932 |
75 | RIPK1 | 0.63153377 |
76 | MAPK12 | 0.62765226 |
77 | SIK1 | 0.62285832 |
78 | FGFR4 | 0.61317635 |
79 | MAPK7 | 0.60475051 |
80 | MAP2K3 | 0.58127841 |
81 | SIK2 | 0.56688560 |
82 | MAP2K6 | 0.56639600 |
83 | RPS6KL1 | 0.56529156 |
84 | RPS6KC1 | 0.56529156 |
85 | DAPK2 | 0.56268139 |
86 | MAP3K1 | 0.56182031 |
87 | FGFR3 | 0.55751836 |
88 | TGFBR1 | 0.53352383 |
89 | TRPM7 | 0.53306122 |
90 | IRAK2 | 0.51840336 |
91 | CAMKK1 | 0.49852505 |
92 | CAMK1D | 0.49808359 |
93 | STK3 | 0.49718595 |
94 | PTK6 | 0.49607426 |
95 | MAP3K6 | 0.49603854 |
96 | MAP3K12 | 0.47807343 |
97 | ERBB4 | 0.47364454 |
98 | ARAF | 0.47102913 |
99 | LRRK2 | 0.46143820 |
100 | BMPR1B | 0.46080633 |
101 | ERBB3 | 0.45378485 |
102 | CLK1 | 0.44916909 |
103 | MAPKAPK2 | 0.42973892 |
104 | RPS6KA2 | 0.42312802 |
105 | FYN | 0.42259814 |
106 | ITK | 0.41837062 |
107 | PDGFRB | 0.40897992 |
108 | STK4 | 0.39958754 |
109 | CDK6 | 0.35715512 |
110 | TESK1 | 0.35676225 |
111 | PAK4 | 0.35378582 |
112 | CAMK1G | 0.32661862 |
113 | GSK3A | 0.32418454 |
114 | IGF1R | 0.32328745 |
115 | TTN | 0.30390473 |
116 | SGK3 | 0.29221634 |
117 | DAPK3 | 0.29202748 |
118 | PIK3CG | 0.27693791 |
119 | KSR1 | 0.27500783 |
120 | MAP2K4 | 0.25809256 |
121 | PRKCQ | 0.25620340 |
122 | INSR | 0.25361058 |
123 | MAP3K10 | 0.23197112 |
124 | RPS6KA6 | 0.22531676 |
125 | MAPK4 | 0.22523670 |
126 | PRKG2 | 0.21988004 |
127 | PDK1 | 0.21755647 |
128 | PDPK1 | 0.21532157 |
129 | MAP2K2 | 0.20951524 |
130 | PLK2 | 0.20362198 |
131 | SRC | 0.20253403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.98249014 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.71160299 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.54904285 |
4 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.87847667 |
5 | * Legionellosis_Homo sapiens_hsa05134 | 2.75684983 |
6 | Malaria_Homo sapiens_hsa05144 | 2.66172716 |
7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.62454716 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.50923119 |
9 | * Pertussis_Homo sapiens_hsa05133 | 2.48072420 |
10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.43006367 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38410728 |
12 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.37584792 |
13 | * Tuberculosis_Homo sapiens_hsa05152 | 2.33449269 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 2.26894051 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23850717 |
16 | Lysosome_Homo sapiens_hsa04142 | 2.16380092 |
17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15087993 |
18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.95424192 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94082880 |
20 | Measles_Homo sapiens_hsa05162 | 1.93291771 |
21 | Asthma_Homo sapiens_hsa05310 | 1.91004475 |
22 | * Salmonella infection_Homo sapiens_hsa05132 | 1.85949390 |
23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.83949419 |
24 | * Phagosome_Homo sapiens_hsa04145 | 1.81465181 |
25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.76009373 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.70589010 |
27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57230597 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51910192 |
29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49775403 |
30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43528722 |
31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41401202 |
32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37592939 |
33 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37099520 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33564731 |
35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26978481 |
36 | Prion diseases_Homo sapiens_hsa05020 | 1.26650100 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24816874 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.22375601 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.19269229 |
40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17899100 |
41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13024287 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10271841 |
43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05326672 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03729364 |
45 | * Amoebiasis_Homo sapiens_hsa05146 | 1.02589208 |
46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00106579 |
47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99886896 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 0.99107039 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 0.93294844 |
50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89333538 |
51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87742246 |
52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84790230 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84749499 |
54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83415196 |
55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77588496 |
56 | Bladder cancer_Homo sapiens_hsa05219 | 0.67808573 |
57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65336527 |
58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63770584 |
59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61283808 |
60 | Mineral absorption_Homo sapiens_hsa04978 | 0.60847024 |
61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56709990 |
62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56228626 |
63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55427002 |
64 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52928079 |
65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50818002 |
66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47796157 |
67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47252228 |
68 | Platelet activation_Homo sapiens_hsa04611 | 0.46726321 |
69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46397076 |
70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45796837 |
71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44629734 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42173556 |
73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42124650 |
74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40373962 |
75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40061100 |
76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39792792 |
77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39133196 |
78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38789008 |
79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38667644 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38550455 |
81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36786880 |
82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36727950 |
83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36347904 |
84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34402492 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.34019199 |
86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33919108 |
87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31932758 |
88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31906825 |
89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29989360 |
90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29552053 |
91 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26227502 |
92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23444978 |
93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22506846 |
94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22291397 |
95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22050874 |
96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21115945 |
97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20358583 |
98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20006591 |
99 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19844778 |
100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19060497 |
101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18744081 |
102 | Insulin resistance_Homo sapiens_hsa04931 | 0.18197872 |
103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.17536718 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17412390 |
105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16990978 |
106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16594012 |
107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13961053 |
108 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13605231 |
109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13504781 |
110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.13071482 |
111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12885143 |
112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11417712 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10816881 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07446876 |